Stay updated with breaking news from Jun Ma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
For patients receiving concurrent chemoradiotherapy for squamous cell carcinoma of the head and neck, higher doses of gabapentin are well tolerated and associated with delayed time to first opioid use for additional pain control during radiotherapy.
For patients receiving concurrent chemoradiotherapy for squamous cell carcinoma of the head and neck, higher doses of gabapentin are well tolerated and associated with delayed time to first opioid use for additional pain control during radiotherapy.
The time to first opioid use for additional pain control was greatest in the 3,600-mg cohort in the multivariable competing risks model.
Higher doses of prophylactic gabapentin can delay, reduce or eliminate pain in patients with head and neck cancer.
/PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to...